Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis

This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor agonist, loperamide, administered topically in a liposomal gel formulation on pain, inflammation, and disease progression in the adjuvant-induced model of experimental rheumatoid arthritis in female Lewis r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Susan, Dias, Thilani H., Pepperall, Debbie-Gai, Yang, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539122/
https://www.ncbi.nlm.nih.gov/pubmed/28824428
http://dx.doi.org/10.3389/fphar.2017.00503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539122/
https://www.ncbi.nlm.nih.gov/pubmed/28824428
http://dx.doi.org/10.3389/fphar.2017.00503

Ejemplares similares